Selective serotonin reuptake inhibitors use in pregnancy: a risk assessment study using administrative pharmaceutical data
Background Antidepressant management with Selective Serotonin Reuptake Inhibitors (SSRI) during pregnancy is associated with risks of congenital malformations and adverse pregnancy outcomes. Main Aim We examined the incidence of SSRI use during pregnancy using Australian administrative pharmaceu...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Swansea University
2019-11-01
|
Series: | International Journal of Population Data Science |
Online Access: | https://ijpds.org/article/view/1167 |